Titlebook: Advances in Radiation Oncology in Lung Cancer; Branislav Jeremić Book 2023Latest edition The Editor(s) (if applicable) and The Author(s),

ARK

辩论

PET and PET/CT in Treatment Planningrticularly for those who are candidates for potentially curative radiation therapy (RT) (Akhurst et al. 2015; De Ruysscher et al. 2010). .F-Fluorodeoxyglucose (.F-FDG) remains the most widely used PET radiopharmaceutical in oncology and FDG-PET has proven to be the most accurate whole-body imaging m

precede

pacifist

excursion

FLORA

fabricate

宿醉

Towards Sustained Team Effectivenessy, thus contributing to cancer development. In this chapter, the different epigenetic processes that are disrupted in cancer cells are described with special focus on the genetic abnormalities that disturb chromatin stability to promote lung cancer development.

装饰

异常

Dynamical Systems and Internal Modelso therapeutic decision-making will also be described, and a multimodality approach for a comprehensive diagnosis of advanced NSCLC including predictive biomarker testing will be discussed. Finally, given that the scope of this publication is radiation oncology, the chapter will end with a discussion